Wird geladen...
Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate
OBJECTIVES: To determine the predictive factors of clinical response to infliximab in patients with refractory psoriatic polyarthritis. METHODS: A multicentre open study which included 69 patients with psoriatic polyarthritis refractory to methotrexate (15 mg/week at least for 8 weeks). Patients wer...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Group
2007
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1856049/ https://ncbi.nlm.nih.gov/pubmed/17179176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.060079 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|